Showing 221-230 of 9351 results for "".
Allergan Board Rejects Latest Valeant Bid; Topical Jublia Approved for Onychomycosis
https://practicaldermatology.com/series/dermwire-tv/dwtv-6-12/19122/Allergan's board rejects the latest merger proposal from Valeant and the FDA approves topical Jublia for onychomycosis. LEarn about these developments and hear from the AMA's new president in this edition of DermWireTV.ASDS: Dr. Farah on Hair Loss Treatment Options
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-dr-farah-hair-regrowth-options/29152/Ronda Farah, MD, discusses treatment options for hair loss, including platelet-rich plasma and lasers, at the 2024 American Society for Dermatologic Surgery Annual Meeting.DermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cosmetic-surgery-forum-highlights-leo-focuses-on-ad/19703/New treatments and medical controversies take center stage at Cosmetic Surgery Forum as the meeting moves to Nashville in its 11th Year. Leo Pharma’s tralokinumab meets all primary and secondary endpoints in three pivotal Phase 3 studies for the treatment of adults with moderate-to-severe atopic derTaltz Approved, Venus Versa Cleared, Sunbathing Linked to Longevity
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-taltz-approved-venus-versa-cleared-sunbathing-linked-to-longevity/18788/The IL-17 inhibitor Taltz (ixekizumab) from Eli Lilly is approved for adults with plaque psoriasis. Venus Concepts' Venus Versa is cleared for multiple aesthetic indications. Strata Sciences gets FDA clearance for new "Classifier Code" for use with MelaFind. Vitals.com shows that wait times are goinAchieving Optimal Outcomes with Laser Surgery
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/achieving-optimal-outcomes-with-laser-surgery/18818/Eric Bernstein, MD discusses a variety of laser and light devices and their benefits in treating a myriad of dermatological conditions as well as for cosmetic concerns. He also shares tips for how to use the devices safely to ensure optimal outcomes and to avoid adverse events.An Off-Label Adjuvant Treatment for Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermtube-journal-club-alam-part-2/18642/In part two of DermTube Journal Club Host Dr. Joshua Zeichner's interview with Murad Alam, MD, they talk about the role of imiquimod as an adjuvant therapy in treating melanoma. Dr. Alam describes how he uses imiquimod off-label after removing melanoma to help prevent recurrence. He also shares howThe Economical ADVANTAGE Diode Laser Treats Chest and Abs Hair In Under 5 Minutes
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-economical-advantage-diode-laser-treats-chest-and-abs-hair-in-under-5-minutes/19213/ADVANTAGE™ Diode Laser Hair Removal System, offers clinics an economical way to have speed and efficacy in a small footprint. The 10 x 30 mm handpiece delivers impressive speed for efficacious LHR as demonstrated by Dr. Melanie Palm. The male patient in this video has his unwanted chest and abs hairAdvances in Hair Loss Treatments
https://practicaldermatology.com/conferences/scale-2025/advances-in-hair-loss-treatments/35899/Marc R. Avram, MD, talks at Music City SCALE 2025 about hair loss and advances in platelet-rich plasma (PRP), lasers, and transplantation.AAD Leaders Discuss New Goals and Initiatives
https://practicaldermatology.com/series/dermwire-tv/aad-leaders-discuss-new-goals-and-initiatives/33154/In this week's DermwireTV, leaders of the American Academy of Dermatology (AAD) discuss the key issues facing the specialty; a new study examines nicotinamide exposure and the risk of major adverse cardiovascular events; and in our C-Suite Chats segment, we hear from an Executive Director at TakeSCALE 2024: Dr. Linda Stein Gold on What’s New and What’s Coming in AD
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-linda-stein-gold-on-whats-new-and-whats-coming-in-ad/26412/Linda Stein Gold, MD, discusses new topical, oral, and biologic drugs for the treatment of atopic dermatitis at Music City SCALE.